Table 3.
Adjusted HR of CRC incidence and of CRC mortality in subjects with a positive FIT, with 95% CIs
| Adjusted* HR | 95% CI | |
| CRC incidence† | ||
| Gender | ||
| Male | 1.00 | – |
| Female | 0.84 | 0.79 to 0.89 |
| Age at time of FIT (years) | ||
| 50–59 | 1.00 | – |
| 60–69 | 1.7 | 1.59 to 1.80 |
| Screening round | ||
| First | 1.00 | – |
| Subsequent | 0.5 | 0.47 to 0.53 |
| Compliance with colonoscopy | ||
| Yes | 1.00 | – |
| No (up to month 6) | 0.56 | 0.51 to 0.61 |
| No (beyond month 6) | 3.68 | 3.20 to 4.22 |
| CRC mortality‡ | ||
| Gender | ||
| Male | 1.00 | – |
| Female | 0.68 | 0.56 to 0.81 |
| Age at time of FIT (years) | ||
| 50–59 | 1.00 | – |
| 60–69 | 1.88 | 1.56 to 2.26 |
| Screening round | ||
| First | 1.00 | – |
| Subsequent | 0.45 | 0.37 to 0.54 |
| Compliance with colonoscopy | ||
| Yes | 1.00 | – |
| No | 2.03 | 1.68 to 2.44 |
*Adjusted by all the variables reported in the table.
†According to Extended-Cox model.
‡According to Cox model.
CRC, colorectal cancer; FIT, faecal immunochemical test.